The impact of demographic, clinical, genetic, and imaging variables on tau PET status

PURPOSE: A substantial proportion of amyloid-β (Aβ)+ patients with clinically diagnosed Alzheimer’s disease (AD) dementia and mild cognitive impairment (MCI) are tau PET–negative, while some clinically diagnosed non-AD neurodegenerative disorder (non-AD) patients or cognitively unimpaired (CU) subje...

Descripción completa

Detalles Bibliográficos
Autores principales: Ossenkoppele, Rik, Leuzy, Antoine, Cho, Hanna, Sudre, Carole H., Strandberg, Olof, Smith, Ruben, Palmqvist, Sebastian, Mattsson-Carlgren, Niklas, Olsson, Tomas, Jögi, Jonas, Stormrud, Erik, Ryu, Young Hoon, Choi, Jae Yong, Boxer, Adam L., Gorno-Tempini, Maria L., Miller, Bruce L., Soleimani-Meigooni, David, Iaccarino, Leonardo, La Joie, Renaud, Borroni, Edilio, Klein, Gregory, Pontecorvo, Michael J., Devous, Michael D., Villeneuve, Sylvia, Lyoo, Chul Hyoung, Rabinovici, Gil D., Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131404/
https://www.ncbi.nlm.nih.gov/pubmed/33215319
http://dx.doi.org/10.1007/s00259-020-05099-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131404/
https://www.ncbi.nlm.nih.gov/pubmed/33215319
http://dx.doi.org/10.1007/s00259-020-05099-w

Ejemplares similares